Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 1
1990 1
1991 1
1992 4
1993 3
1994 4
1995 2
1996 1
1997 6
1998 8
1999 7
2000 2
2001 4
2003 2
2005 1
2006 2
2007 2
2010 1
2011 1
2012 1
2013 2
2015 1
2017 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

59 results
Results by year
Filters applied: . Clear all
Page 1
Muscarinic mechanisms of antipsychotic atypicality.
Bymaster FP, Felder CC, Tzavara E, Nomikos GG, Calligaro DO, Mckinzie DL. Bymaster FP, et al. Among authors: calligaro do. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1125-43. doi: 10.1016/j.pnpbp.2003.09.008. Prog Neuropsychopharmacol Biol Psychiatry. 2003. PMID: 14642972 Review.
A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder.
Upadhyaya HP, Desaiah D, Schuh KJ, Bymaster FP, Kallman MJ, Clarke DO, Durell TM, Trzepacz PT, Calligaro DO, Nisenbaum ES, Emmerson PJ, Schuh LM, Bickel WK, Allen AJ. Upadhyaya HP, et al. Among authors: calligaro do. Psychopharmacology (Berl). 2013 Mar;226(2):189-200. doi: 10.1007/s00213-013-2986-z. Epub 2013 Feb 9. Psychopharmacology (Berl). 2013. PMID: 23397050 Free PMC article. Review.
A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data.
Kennedy JS, Bymaster FP, Schuh L, Calligaro DO, Nomikos G, Felder CC, Bernauer M, Kinon BJ, Baker RW, Hay D, Roth HJ, Dossenbach M, Kaiser C, Beasley CM, Holcombe JH, Effron MB, Breier A. Kennedy JS, et al. Among authors: calligaro do. Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S33-61. doi: 10.1002/1099-1166(200112)16:1+<::aid-gps571>3.0.co;2-5. Int J Geriatr Psychiatry. 2001. PMID: 11748788 Review.
Olanzapine: a basic science update.
Bymaster F, Perry KW, Nelson DL, Wong DT, Rasmussen K, Moore NA, Calligaro DO. Bymaster F, et al. Among authors: calligaro do. Br J Psychiatry Suppl. 1999;(37):36-40. Br J Psychiatry Suppl. 1999. PMID: 10211140 Review.
Preclinical predictors that the orthosteric mGlu2/3 receptor antagonist LY3020371 will not engender ketamine-associated neurotoxic, motor, cognitive, subjective, or abuse-liability-related effects.
Witkin JM, Monn JA, Li J, Johnson B, McKinzie DL, Wang XS, Heinz BA, Li R, Ornstein PL, Smith SC, Mitch CH, Calligaro DO, Swanson S, Allen D, Phillips K, Gilmour G. Witkin JM, et al. Among authors: calligaro do. Pharmacol Biochem Behav. 2017 Apr;155:43-55. doi: 10.1016/j.pbb.2017.03.001. Epub 2017 Mar 8. Pharmacol Biochem Behav. 2017. PMID: 28285123
The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans.
May PC, Willis BA, Lowe SL, Dean RA, Monk SA, Cocke PJ, Audia JE, Boggs LN, Borders AR, Brier RA, Calligaro DO, Day TA, Ereshefsky L, Erickson JA, Gevorkyan H, Gonzales CR, James DE, Jhee SS, Komjathy SF, Li L, Lindstrom TD, Mathes BM, Martényi F, Sheehan SM, Stout SL, Timm DE, Vaught GM, Watson BM, Winneroski LL, Yang Z, Mergott DJ. May PC, et al. Among authors: calligaro do. J Neurosci. 2015 Jan 21;35(3):1199-210. doi: 10.1523/JNEUROSCI.4129-14.2015. J Neurosci. 2015. PMID: 25609634 Free PMC article. Clinical Trial.
Central and peripheral cocaine receptors.
Calligaro DO, Eldefrawi ME. Calligaro DO, et al. J Pharmacol Exp Ther. 1987 Oct;243(1):61-8. J Pharmacol Exp Ther. 1987. PMID: 2822906
59 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page